Hancock Whitney’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.48M | Sell |
9,004
-49
| -0.5% | -$18.2K | 0.06% | 235 |
|
|
2026
Q1 | $2.8M | Buy |
9,053
+855
| +10% | +$281K | 0.05% | 268 |
|
|
2025
Q4 | $2.87M | Buy |
8,198
+201
| +3% | +$67.9K | 0.05% | 243 |
|
|
2025
Q3 | $2.58M | Buy |
7,997
+1,092
| +16% | +$340K | 0.05% | 260 |
|
|
2025
Q2 | $2.69M | Buy |
6,905
+4,920
| +248% | +$1.98M | 0.05% | 245 |
|
|
2025
Q1 | $863K | Sell |
1,985
-95
| -5% | -$38.1K | 0.03% | 337 |
|
|
2024
Q4 | $767K | Sell |
2,080
-429
| -17% | -$180K | 0.02% | 353 |
|
|
2024
Q3 | $1.3M | Sell |
2,509
-940
| -27% | -$502K | 0.04% | 268 |
|
|
2024
Q2 | $1.87M | Sell |
3,449
-127
| -4% | -$67.1K | 0.06% | 202 |
|
|
2024
Q1 | $1.85M | Buy |
3,576
+116
| +3% | +$57.7K | 0.06% | 203 |
|
|
2023
Q4 | $1.63M | Sell |
3,460
-40
| -1% | -$18.5K | 0.06% | 224 |
|
|
2023
Q3 | $1.52M | Sell |
3,500
-245
| -7% | -$111K | 0.06% | 221 |
|
|
2023
Q2 | $1.66M | Buy |
3,745
+55
| +1% | +$25.4K | 0.07% | 220 |
|
|
2023
Q1 | $1.7M | Sell |
3,690
-102
| -3% | -$48.5K | 0.07% | 224 |
|
|
2022
Q4 | $1.95M | Sell |
3,792
-139
| -4% | -$70.6K | 0.08% | 212 |
|
|
2022
Q3 | $1.79M | Buy |
3,931
+173
| +5% | +$82.8K | 0.08% | 209 |
|
|
2022
Q2 | $1.81M | Sell |
3,758
-95
| -2% | -$47K | 0.07% | 218 |
|
|
2022
Q1 | $1.89M | Sell |
3,853
-184
| -5% | -$84.1K | 0.06% | 239 |
|
|
2021
Q4 | $1.87M | Sell |
4,037
-69
| -2% | -$29K | 0.06% | 251 |
|
|
2021
Q3 | $1.53M | Sell |
4,106
-346
| -8% | -$131K | 0.05% | 274 |
|
|
2021
Q2 | $1.7M | Sell |
4,452
-110
| -2% | -$42K | 0.05% | 316 |
|
|
2021
Q1 | $1.64M | Sell |
4,562
-1,678
| -27% | -$540K | 0.06% | 318 |
|
|
2020
Q4 | $2M | Sell |
6,240
-364
| -6% | -$112K | 0.07% | 267 |
|
|
2020
Q3 | $1.77M | Buy |
6,604
+1,654
| +33% | +$445K | 0.07% | 242 |
|
|
2020
Q2 | $1.3M | Sell |
4,950
-86
| -2% | -$22.9K | 0.05% | 320 |
|
|
2020
Q1 | $1.14M | Sell |
5,036
-4,983
| -50% | -$1.36M | 0.04% | 343 |
|
|
2019
Q4 | $3.03M | Sell |
10,019
-2,186
| -18% | -$602K | 0.1% | 236 |
|
|
2019
Q3 | $2.93M | Sell |
12,205
-226
| -2% | -$61.9K | 0.1% | 249 |
|
|
2019
Q2 | $3.51M | Sell |
12,431
-1,206
| -9% | -$329K | 0.11% | 230 |
|
|
2019
Q1 | $3.91M | Sell |
13,637
-755
| -5% | -$218K | 0.13% | 220 |
|
|
2018
Q4 | $3.78M | Sell |
14,392
-289
| -2% | -$79.5K | 0.13% | 220 |
|
|
2018
Q3 | $4.02M | Buy |
14,681
+4,464
| +44% | +$1.16M | 0.11% | 228 |
|
|
2018
Q2 | $2.43M | Sell |
10,217
-320
| -3% | -$74.1K | 0.11% | 181 |
|
|
2018
Q1 | $2.31M | Sell |
10,537
-163
| -2% | -$38.3K | 0.1% | 179 |
|
|
2017
Q4 | $2.41M | Sell |
10,700
-1,248
| -10% | -$266K | 0.1% | 187 |
|
|
2017
Q3 | $2.27M | Sell |
11,948
-905
| -7% | -$172K | 0.1% | 181 |
|
|
2017
Q2 | $2.42M | Sell |
12,853
-695
| -5% | -$125K | 0.1% | 186 |
|
|
2017
Q1 | $2.24M | Buy |
+13,548
| New | +$2.16M | 0.09% | 197 |
|
|
2015
Q4 | – | Sell |
-8,550
| Closed | -$1.2M | – | 539 |
|
|
2015
Q3 | $1.2M | Buy |
8,550
+160
| +2% | +$24K | 0.05% | 276 |
|
|
2015
Q2 | $1.3M | Hold |
8,390
| – | – | 0.05% | 257 |
|
|
2015
Q1 | $1.3M | Buy |
8,390
+1,200
| +17% | +$171K | 0.05% | 257 |
|
|
2014
Q4 | $904K | Hold |
7,190
| – | – | 0.03% | 274 |
|
|
2014
Q3 | $860K | Hold |
7,190
| – | – | 0.03% | 308 |
|
|
2014
Q2 | $774K | Hold |
7,190
| – | – | 0.03% | 313 |
|
|
2014
Q1 | $716K | Hold |
7,190
| – | – | 0.03% | 310 |
|
|
2013
Q4 | $664K | Sell |
7,190
-70
| -1% | -$6.22K | 0.03% | 308 |
|
|
2013
Q3 | $607K | Sell |
7,260
-375
| -5% | -$32.1K | 0.03% | 305 |
|
|
2013
Q2 | $625K | Buy |
+7,635
| New | +$571K | 0.03% | 299 |
|
Other funds holding ELV
Hancock Whitney's ELV Position: Q2 2026 in Review
Hancock Whitney reduced its Elevance Health (ELV) stake by 0.54% in Q2 2026, selling an estimated $18.2K and leaving 9,004 shares worth $3.48M. The position accounts for 0.06% of the portfolio, ranked #235.
Hancock Whitney first reported a position in ELV in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.02M in Q3 2018. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Hancock Whitney held 9,004 shares of Elevance Health worth $3.48M as of Q2 2026.
- Hancock Whitney sold 49 Elevance Health shares in Q2 2026, an estimated $18.2K.
- Elevance Health made up 0.06% of Hancock Whitney's portfolio in Q2 2026, its #235 holding.
- Hancock Whitney first reported a position in Elevance Health in Q2 2013 and has held it in 48 quarters since.
- Hancock Whitney's Elevance Health position peaked at $4.02M in Q3 2018.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.